<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rmt</journal-id><journal-title-group><journal-title xml:lang="ru">Общая реаниматология</journal-title><trans-title-group xml:lang="en"><trans-title>General Reanimatology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-9779</issn><issn pub-type="epub">2411-7110</issn><publisher><publisher-name>FSBI "SRIGR" RAMS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15360/1813-9779-2020-5-30-36</article-id><article-id custom-type="elpub" pub-id-type="custom">rmt-1965</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ И ПРАКТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES AND PRACTICE</subject></subj-group></article-categories><title-group><article-title>Выбор препарата инфузионной терапии в раннем послеоперационном периоде у детей</article-title><trans-title-group xml:lang="en"><trans-title>Choice of Drug for Intravenous Fluid Therapy in the Early Postoperative Period in Children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лазарев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lazarev</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лазарев Владимир Викторович.117997, Москва, ул. Островитянова, д. 1; 119537, Москва, Ленинский проспект, д. 117.</p></bio><bio xml:lang="en"><p>Vladimir V. Lazarev.1 Ostrovityanova Str., 117997 Moscow; 117 Leninsky Prospekt, 119571 Moscow.</p></bio><email xlink:type="simple">lazarev_vv@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сулайманова</surname><given-names>Ж. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Sulaimanova</surname><given-names>Zh. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, д. 1; 119537, Москва, Ленинский проспект, д. 117.</p></bio><bio xml:lang="en"><p>Zhanara D. Sulaimanova.1 Ostrovityanova Str., 117997 Moscow; 117 Leninsky Prospekt, 119571 Moscow.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цыпин</surname><given-names>Л. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsypin</surname><given-names>L. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, д. 1; 119537, Москва, Ленинский проспект, д. 117.</p></bio><bio xml:lang="en"><p>Leonid E. Tsypin.1 Ostrovityanova Str., 117997 Moscow; 117 Leninsky Prospekt, 119571 Moscow.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брюсов</surname><given-names>Г. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Brusov</surname><given-names>G. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119537, Москва, Ленинский проспект, д. 117.</p></bio><bio xml:lang="en"><p>Gleb P. Brusov.117 Leninsky Prospekt, 119571 Moscow.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еряшева</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Eryasheva</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119537, Москва, Ленинский проспект, д. 117.</p></bio><bio xml:lang="en"><p>Tatiana V. Eryasheva.117 Leninsky Prospekt, 119571 Moscow.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздрава России; Российская детская клиническая больница Российского национального исследовательского медицинского университета им. Н.И. Пирогова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University; Russian Children's Clinical Hospital of the Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Российская детская клиническая больница Российского национального исследовательского медицинского университета им. Н.И. Пирогова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Children's Clinical Hospital of the Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>06</day><month>11</month><year>2020</year></pub-date><volume>16</volume><issue>5</issue><fpage>30</fpage><lpage>36</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лазарев В.В., Сулайманова Ж.Д., Цыпин Л.Е., Брюсов Г.П., Еряшева Т.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Лазарев В.В., Сулайманова Ж.Д., Цыпин Л.Е., Брюсов Г.П., Еряшева Т.В.</copyright-holder><copyright-holder xml:lang="en">Lazarev V.V., Sulaimanova Z.D., Tsypin L.E., Brusov G.P., Eryasheva T.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.reanimatology.com/rmt/article/view/1965">https://www.reanimatology.com/rmt/article/view/1965</self-uri><abstract><p>Выбор препарата стартовой инфузионной терапии в раннем послеоперационном периоде актуален с позиции клинической эффективности, определяющей также и экономическую целесообразность комплекса лечебных мероприятий.Цель исследования. Сравнительная оценка сукцинатсодержащего раствора и раствора 0,9% NaCl в качестве препарата стартовой инфузионной терапии в раннем послеоперационном периоде у детей.Материалы и методы. Провели проспективное рандомизированное исследование методом случайной выборки у 43 пациентов с оценкой по ASA II-III после плановых хирургических вмешательств, длительностью 1-3 часа. В 1-й группе «N», (n=23) дети в раннем послеоперационном периоде (в течение 3 ч после операции) получали непрерывную инфузию раствора 0,9% NaCl, во 2-й группе «R», (n=20) — инфузию в режиме 2,3 (1,6; 2,8) сукцинатсодержащим раствором. Межгрупповое и внутригрупповое различие на этапах исследования оценивали по динамике водно-электролитного и кислотно-основного состояния (КОС), основного обмена и значений фазового угла — расчетного интегрального показателя состояния мембран клеточных структур. Данные регистрировали на 5 этапах исследования: 1 — сразу при поступлении в ОРИТ (исходные данные), 2 — через 60 минут, 3 — через 90 минут, 4 — через 120 минут, 5 — через 180 минут от момента поступления в ОРИТ.Результаты. Концентрация калия в плазме крови значимо различалась между группами через 60 (p=0,01) и 180 минут (p=0,04) после начала инфузии препаратов. В группе N на 2-м этапе отмечали снижение показателя на 7%, а в группе R увеличение на 2,1%, по отношению к исходному значению. К концу исследования концентрация калия снижалась в группе N на 6,9% и в группе R — на 6,5%. Внутригрупповые различия были значимы в группе N на 2-м (p=0,02) и 5-м (p=0,01) этапах. В группе R ни на одном этапе не выявили значимых различий от исходных значений. Во всех случаях значения показателя находились в пределах референсных значений. В группе N на 2-м этапе содержание натрия достоверно повышалось от значений 1-го этапа на 2,1% (p=0,01). В группе R на 5-м этапе наблюдали значимое снижение содержания Cl- на 2,7% (p=0,01). Динамика показателей КОС характеризовалась тенденцией к смешанному ацидозу на 2-м этапе в обеих группах, отмечали одинаковое значимое снижение pH на 1,3% от исходного значения, а к 5-у этапу — снижение pH было более выражено в группе N — на 1,2% от исходного значения, в группе R — на 0,9%, соответственно (p=0,01). В группе N выявили снижение значения фазового угла на 8,6% на 2-м этапе и на 6% к 5-у этапу исследования (p=0,01). В группе R значимых различий в динамике значений фазового угла не обнаружили.Заключение. Сукцинатсодержащий раствор благоприятнее влияет на водно-электролитный баланс, КОС плазмы крови, состояние клеточных мембран в сравнении с раствором 0,9% NaCl.</p></abstract><trans-abstract xml:lang="en"><p>The choice of drug for initial fluid therapy in the early postoperative period is important in terms of clinical efficacy and cost-effectiveness of the combination treatment.The aim of the study was to compare the effects of a succinate-containing solution and 0.9% NaCl solution when used as a drug of initial intravenous fluid therapy in early postoperative period in children.Materials and methods. A prospective randomized trial was conducted with participation of 43 patients having ASA II—III score after elective surgical interventions with a duration of 1-3 hours. In Group I («N») (n=23) the patients received continuous infusion of 0.9% NaCl solution in the early postoperative period (within 3 hours after the operation), in Group 2 («R») (n=20) continuous infusion of a succinate-containing solution was administered in 2.3 (1.6; 2.8) mode. The inter- and intragroup differences during the study were estimated by the changes of water-electrolyte and acid-base balance, basal metabolism, and phase angle (estimated integral index of cellular membranes condition) values. The data were recorded during the 5 stages of the study: 1 — immediately upon ICU admission (baseline), 2 — 60 minutes, 3 — 90 minutes, 4 — 120 minutes, 5 — 180 minutes after the ICU admission.Results. Significant differences in plasma potassium level between the groups 60 minutes (P=0.01) and 180 minutes (P=0.04) after the initiation of drugs infusion were found. In group N, at the 2nd stage, a 7% decrease in the potassium level was observed, while in group R, it increased by 2.1% as compared with the baseline. By the end of the study, potassium level decreased by 6.9% in group N and by 6.5% in group R. The intragroup differences were significant in Group N at the 2nd (P=0.02) and 5th (P=0.01) stages. In group R, no significant differences vs the baseline were found at any stage. In all cases, the values were within the reference values. In group N, at the 2nd stage the sodium concentration increased compared with the 1st stage by 2.1% (P=0.01). In group R, at the 5th stage, a significant decrease of Cl- concentration by 2.7% (P=0.01) was observed. The acid-base status showed a trend towards mixed acidosis at the 2nd stage in both groups, with the similarly significant pH reduction by 1.3% vs the baseline, whereas at 5th stage the decrease of pH was more significant in Group N (by 1.2% vs the baseline) than in Group R (by 0.9%) (P=0.01). In group N, the phase angle value was found to decrease by 8.6% at the 2nd stage and by 6% at the 5th stage (P=0.01). In group R no significant differences in the phase angle values were found.Conclusion. The succinate-containing solution has more favorable effect on the water-electrolyte and blood acid-base balance, as well as the state of cell membranes compared with the 0.9% NaCl solution.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инфузионная терапия</kwd><kwd>0</kwd><kwd>9% NaCl</kwd><kwd>анестезия</kwd><kwd>дети</kwd><kwd>стартовый раствор</kwd><kwd>сукцинат</kwd><kwd>Реамберин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>anesthesia</kwd><kwd>children</kwd><kwd>initial solution</kwd><kwd>succinate</kwd><kwd>0.9% NaCl</kwd><kwd>fluid therapy</kwd><kwd>Reamberin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Steurer M.A., Berger T.M. Infusion therapy for neonates, infants and children. Anaesthesist. 2011; 60 (1): 10-22. PMID: 21181098. DOI: 10.1007/s00101-010-1824-5.</mixed-citation><mixed-citation xml:lang="en">Steurer M.A., Berger T.M. Infusion therapy for neonates, infants and children. Anaesthesist. 2011; 60 (1): 10-22. PMID: 21181098. DOI: 10.1007/s00101-010-1824-5.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Boer C., Bossers S.M., Koning N.J. Choice of fluid type: physiological concepts and perioperative indications. Br J Anaesth. 2018; 120 (2): 384-396. PMID: 29406187. DOI: 10.1016/j.bja.2017.10.022.</mixed-citation><mixed-citation xml:lang="en">Boer C., Bossers S.M., Koning N.J. Choice of fluid type: physiological concepts and perioperative indications. Br J Anaesth. 2018; 120 (2): 384-396. PMID: 29406187. DOI: 10.1016/j.bja.2017.10.022.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ouchi K., Sugiyama K. Hypotonic fluid reduce serum sodium compared to isotonic fluids during anesthesia induction in pediatric patients undergoing maxillofacial surgery-type of infusion affects blood electrolytes and glucose: an observational study. BMC Pediatr. 2016; 16: 112. PMID: 27461484. PMCID: PMC4962346. DOI: 10.1186/s12887-016-0650-6.</mixed-citation><mixed-citation xml:lang="en">Ouchi K., Sugiyama K. Hypotonic fluid reduce serum sodium compared to isotonic fluids during anesthesia induction in pediatric patients undergoing maxillofacial surgery-type of infusion affects blood electrolytes and glucose: an observational study. BMC Pediatr. 2016; 16: 112. PMID: 27461484. PMCID: PMC4962346. DOI: 10.1186/s12887-016-0650-6.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">SUmpelmann R., Becke K., Brenner S., Breschan C., Eich C., Hohne C., Johr M, Kretz F-J, Marx G., Pape L., Schreiber M., Strauss J., Weiss M. Perioperative intravenous fluid therapy in children: guidelines from the Association of the Scientific Medical Societies in Germany. 2017; 27 (1): 10-18. DOI: 10.1111/pan.13007.</mixed-citation><mixed-citation xml:lang="en">SUmpelmann R., Becke K., Brenner S., Breschan C., Eich C., Hohne C., Johr M., Kretz F-J., Marx G., Pape L., Schreiber M., Strauss J., Weiss M. Perioperative intravenous fluid therapy in children: guidelines from the Association of the Scientific Medical Societies in Germany. 2017; 27 (1): 10-18. DOI: 10.1111/pan.13007.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Feld L.G., Neuspiel D.R., Foster B.A., Leu M.G., Garber M.D., Austin K., Basu R.K., Conway Jr.E.E., Fehr J.J., Hawkins C., Kaplan R.L., Rowe E.V., Waseem M., Moritz M.L. and subcommittee on fluid and electrolyte therapy. Clinical Practice Guideline: Maintenance Intravenous Fluids in Children. Pediatrics. 2018;142 (6): 1-12. DOI: 10.1542/peds.2018-3083.</mixed-citation><mixed-citation xml:lang="en">Feld L.G., Neuspiel D.R., Foster B.A., Leu M.G., Garber M.D., Austin K., Basu R.K., Conway Jr.E.E., Fehr J.J., Hawkins C., Kaplan R.L., Rowe E.V., Waseem M., Moritz M.L. and subcommittee on fluid and electrolyte therapy. Clinical Practice Guideline: Maintenance Intravenous Fluids in Children. Pediatrics. 2018; 142 (6): 1-12. DOI: 10.1542/peds.2018-3083.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Moritz M.L., Ayus J.C. Prevention of hospital-acquired hyponatremia: a case for using isotonic saline. Pediatrics. 2003; 111 (2): 227-230. PMID: 12563043. DOI: 10.1542/peds.111.2.227.</mixed-citation><mixed-citation xml:lang="en">Moritz M.L., Ayus J.C. Prevention of hospital-acquired hyponatremia: a case for using isotonic saline. Pediatrics. 2003; 111 (2): 227-230. PMID: 12563043. DOI: 10.1542/peds.111.2.227.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Delpachitra M.R., Namachivayam S.P., Millar J., Delzoppo C., Butt W.W. A Case-Control Analysis of Postoperative Fluid Balance and Mortality After Pediatric Cardiac Surgery. Pediatr Crit Care Med. 2017; 18 (7): 614-622. PMID: 28492405. DOI: 10.1097/PCC.0000000000001170.</mixed-citation><mixed-citation xml:lang="en">Delpachitra M.R., Namachivayam S.P., Millar J., Delzoppo C., Butt W.W. A Case-Control Analysis of Postoperative Fluid Balance and Mortality After Pediatric Cardiac Surgery. Pediatr Crit Care Med. 2017; 18 (7): 614-622. PMID: 28492405. DOI: 10.1097/PCC.0000000000001170.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lobo D.N., Awad S. Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent ‘pre-renal' acute kidney injury? Kidney International. 2014; 86 (6): 1096-1105. PMID: 24717302. PMCID: PMC4255073. DOI: 10.1038/ki.2014.105.</mixed-citation><mixed-citation xml:lang="en">Lobo D.N., Awad S. Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent ‘pre-renal' acute kidney injury? Kidney International. 2014; 86 (6): 1096-1105. PMID: 24717302. PMCID: PMC4255073. DOI: 10.1038/ki.2014.105.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Oh G.J., Sutherland S.M. Perioperative fluid management and postoperative hyponatremia in children. Pediatr Nephrol. 2016; 31 (1): 5360. PMID: 25784018. DOI: 10.1007/s00467-015-3081-y.</mixed-citation><mixed-citation xml:lang="en">Oh G.J., Sutherland S.M. Perioperative fluid management and postoperative hyponatremia in children. Pediatr Nephrol. 2016; 31 (1): 5360. PMID: 25784018. DOI: 10.1007/s00467-015-3081-y.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">De Luca U., Mangia G., Tesoro S., Martino A., Sammartino M,. Calisti A. Guidelines on pediatric day surgery of the Italian Societies of Pediatric Surgery (SICP) and Pediatric Anesthesiology (SARNePI) (review). Italian Journal of Pediatrics. 2018; 44: 35. DOI: 10.1186/s13052-018-0473-1.</mixed-citation><mixed-citation xml:lang="en">De Luca U., Mangia G., Tesoro S., Martino A., Sammartino M,. Calisti A. Guidelines on pediatric day surgery of the Italian Societies of Pediatric Surgery (SICP) and Pediatric Anesthesiology (SARNePI) (review). Italian Journal of Pediatrics. 2018; 44: 35. DOI: 10.1186/s13052-018-0473-1.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Мазина Н.К., Шешунов И.В., Мазин П.В. Адъювантная энергопротекция Реамберином в практике интенсивной терапии и реанимации: эффективность по данным метаанализа (систематический обзор). Анестезиология и реаниматология. 2016; 61 (4): 314-319.</mixed-citation><mixed-citation xml:lang="en">Mazina N.K., Sheshunov I.V., Mazin P.V.. Adjuvant energy protection with Reamberin in the practice of intensive care medicine: efficacy according .to meta-analysis (systematic review). Anestesiol. i reanimatol. 2016; 61 (4): 314-319. [In Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Мазина Н.К., Мазин П.В., Романцов М.Г. Фармакоэкономическое обоснование применения реамберина при ургентных состояниях. Фундаментальные исследования. 2012; 7 (1): 116-122.</mixed-citation><mixed-citation xml:lang="en">Mazina N. K., Mazin P. V., Romantsov M. G. Pharmacoeconomic rationale for the use of Reamberin in urgent conditions. Fundamental-nye issledovaniya. 2012; 7 (1): 116-122. [In Russ.].</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Минина К.З., Демина Т.В., Килимничеснко О.И., Хомяков А.Н., Тиотова Т.П., Степанова А.А. Реамберин в интенсивной терапии послеоперационного септического шока при челюстно — лицевой гнойной патологии. Вестник Украинской медицинской стоматологической академии. 9 (1): 305-307.</mixed-citation><mixed-citation xml:lang="en">Minina K.Z., Demina T.V., Kilimnichesnko O.I., Homyakov A.N., Tio-tova T.P., Stepanova A.A. Reamberin in intensive care of postoperative septic shock in case of maxillofacial purulent pathology. Vestnik Ukrainskoj meditsinskoj stomatologicheskoj akademii. 9 (1): 305-307. [In Russ.].</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Орлов Ю.П., Лукач В.Н., Глущенко А.В. Реамберин в программе интенсивной терапии у пациентов с распространенным перитонитом. Новости хирургии. 2013; 21 (5): 58-64.</mixed-citation><mixed-citation xml:lang="en">Orlov Yu.P., Lukach V.N., Glushchenko A.V. Reamberin in the intensive care program for patients with advanced peritonitis. Novosti khirur-gii. 2013; 21 (5): 58-64. [In Russ.].</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
